AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCowen, K. C
Right arrow Articles by Bistrian, B. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCowen, K. C
Right arrow Articles by Bistrian, B. R
Agricola
Right arrow Articles by McCowen, K. C
Right arrow Articles by Bistrian, B. R
American Journal of Clinical Nutrition, Vol. 75, No. 5, 931-935, May 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Patterns of plasma leptin and insulin concentrations in hospitalized patients after the initiation of total parenteral nutrition1,2

Karen C McCowen, Pei Ra Ling, Charles Friel, Jeffrey Sternberg, R Armour Forse, Peter A Burke and Bruce R Bistrian

1 From the Nutrition Support Service, Departments of Medicine and Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston.

Background: The regulation of leptin in patients with critical illness is poorly understood. Sex, diet, body mass, and cytokines may all play a role.

Objective: The aims of this study were to determine the factors influencing leptin concentrations in hospitalized patients beginning total parenteral nutrition (TPN) and whether a 3-d regimen of TPN would further increase plasma leptin concentrations above baseline.

Design: Twenty-six patients requiring TPN were enrolled in this prospective, nonintervention study. Only 20 (11 women and 9 men) completed all 3 d of TPN.

Results: Baseline plasma leptin in the TPN patients ranged from 62.5 to 1625 pmol/L ( ± SD: 419 ± 387; n = 26) and was not significantly different between men (444 ± 494 pmol/L) and women (363 ± 244 pmol/L). Baseline plasma insulin ranged from 76 to 695 pmol/L (271 ± 188; n = 26) and was not correlated with plasma leptin. Leptin concentrations increased after 3 d of TPN, from 356 ± 300 to 794 ± 600 pmol/L (P < 0.05) in parallel with an increase in insulin from 257 ± 187 to 979 ± 917 pmol/L (P < 0.01) in the 20 patients who completed the study; however, the changes were not correlated when expressed as percentages. Although the men and women had insulin responses to feeding that were not significantly different, leptin concentrations did not increase significantly in men but increased 3-fold in women (to 1094 ± 638 pmol/L; P < 0.01).

Conclusions: Leptin regulation in patients with a critical illness differs substantially from that in healthy persons. The importance of glucose and insulin in leptin secretion remains unclear, especially in men.

Key Words: Total parenteral nutrition • TPN • leptin • insulin • fasting • critical illness • cytokines • sex differences • body mass







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition